ReviewDiabetes2024

Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.

Esther Latres et al.PubMed ↗Publisher ↗

No numbers read from the abstract.